Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | $4,721.7M | $3,677.4M | $11.0B | $9,392.9M | $6,365.7M | $6,523.9M | $13.5B | $7,317.2M | $5,302.0M | ($1,537.0M) | $3,370.0M | $2,876.0M | $3,231.0M | $18.3B | $15.5B | $15.0B | $12.7B | $9,002.0M | $7,776.0M | $8,594.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Abbott Laboratories's last 12-month Net Debt is $7,191.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Abbott Laboratories's Net Debt growth was (15.2%). The average annual Net Debt growth rates for Abbott Laboratories have been (10.6%) over the past three years, (14.2%) over the past five years.
Over the last year, Abbott Laboratories's Net Debt growth was (15.2%), which is lower than industry growth of (0.4%). It indicates that Abbott Laboratories's Net Debt growth is Good.